IBRN · iShares

iShares Neuroscience and Healthcare ETF

See how 80 reported holdings combine into this ETF’s P/E and P/S. Market value, signed ordinary earnings and revenue are added before each ratio is calculated.

Holdings dated 21 August 2026Price US$32.55 as of 2 October 2026Coverage limitations apply

Core valuation

Trailing P/E-17.43×87.55% coverage

Latest-quarter run-rate P/E-15.32×87.55% coverage

Trailing P/S4.79×57.82% coverage

Latest-quarter run-rate P/S4.34×55.02% coverage

Coverage is the share of positive eligible-equity holding value represented in each metric. The published holdings account for 100.00% of fund weight. The reliability standard requires at least 90.00% disclosed fund weight and metric coverage, with no individual uncovered holding above 1.00%.

Largest reported holdings

Largest reported ETF holdings with weights and trailing valuation ratios
Holding	Weight	Trailing P/E	Trailing P/S
PRAXPRAXIS PRECISION MEDICINES	5.49%	-23.62×	Unavailable
DNTHDIANTHUS THERAPEUTICS INC	5.12%	-25.70×	2426.39×
ACADACADIA PHARMACEUTICALS	4.94%	9.01×	3.01×
SRRKSCHOLAR ROCK HOLDING	4.74%	-13.76×	Unavailable
ARWRARROWHEAD PHARMACEUTICALS	4.42%	-28.60×	13.67×
XENEXENON PHARMACEUTICALS	4.36%	-9.21×	Unavailable
ARGXARGENX SE ADR	4.33%	38.91×	12.18×
ALKSALKERMES	4.19%	102.86×	4.08×
BIIBBIOGEN	4.12%	23.98×	3.31×
DNLIDENALI THERAPEUTICS	3.67%	-6.42×	910.56×

Top 10 of 80 reported holdings. * A holding uses its latest full-year result only when both trailing and latest-quarter inputs are unavailable; open the stock for the exact year end.

Most similar funds

Ranked by shared weight across matching disclosed company holdings and explicitly reported same-currency cash.

FBT · First Trust NYSE Arca Biotechnology Index Fund22.73% holdings overlap · NYSE Arca
IBBQ · Invesco Nasdaq Biotechnology ETF15.53% holdings overlap · US market
PBE · Invesco Biotechnology & Genome ETF15.53% holdings overlap · US market
XBI · State Street SPDR S&P Biotech ETF14.31% holdings overlap · NYSE Arca
IBB · iShares Biotechnology ETF12.90% holdings overlap · US market

Sources and limitations

Holdings are sourced from iShares and company financial inputs retain primary-source links. Monetary values are normalised to USD. Corporate actions, reporting lags, unmapped securities and cash can create differences from provider figures.

Open official holdings source

Research holdings date: 21 August 2026. Informational research, not investment advice.